# Phase 1/2a to Assess the Safety and Tolerability of TP-122A for the Treatment of Ventilator-Associated Pneumonia

> **NCT06370598** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Technophage, SA** · enrollment: 15 (estimated)

## Conditions studied

- Pneumonia, Ventilator-Associated

## Interventions

- **BIOLOGICAL:** TP-122A

## Key facts

- **NCT ID:** NCT06370598
- **Lead sponsor:** Technophage, SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-09
- **Primary completion:** 2025-05
- **Final completion:** 2025-06
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2024-04-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06370598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06370598, "Phase 1/2a to Assess the Safety and Tolerability of TP-122A for the Treatment of Ventilator-Associated Pneumonia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06370598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*